Market Overview

Akebia Therapeutics (NASDAQ: AKBA)

3.09 -0.02 (-0.64%)

Analyst Ratings

DateResearch FirmActionCurrentPT
10/26/20HC Wainwright & Co.MaintainsBuy9.0
9/04/20Morgan StanleyMaintainsEqual-Weight3.0
9/04/20BTIGMaintainsBuy6.0
9/04/20HC Wainwright & Co.MaintainsBuy10.0
7/15/20Morgan StanleyMaintainsEqual-Weight12.0
5/06/20JP MorganMaintainsOverweight18.0
5/06/20Morgan StanleyMaintainsEqual-Weight11.0
5/06/20H.C. WainwrightMaintainsBuy17.0
5/06/20MizuhoMaintainsBuy17.0
5/05/20NeedhamMaintainsBuy18.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter